Supplementation with α-KG restored the growth and survival of glutamine-deficient pancreatic cancer cells with the help of glutamate-ammonia ligase (GLUL), which was elevated in the KRASG12D-induced mouse PDAC model (Bott et al., 2019). This evidence concerns the gene GLUL and pancreatic neoplasm.